1. Home
  2. CLSD vs FOXX Comparison

CLSD vs FOXX Comparison

Compare CLSD & FOXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLSD
  • FOXX
  • Stock Information
  • Founded
  • CLSD 2011
  • FOXX 2017
  • Country
  • CLSD United States
  • FOXX United States
  • Employees
  • CLSD N/A
  • FOXX N/A
  • Industry
  • CLSD Biotechnology: Pharmaceutical Preparations
  • FOXX
  • Sector
  • CLSD Health Care
  • FOXX
  • Exchange
  • CLSD Nasdaq
  • FOXX Nasdaq
  • Market Cap
  • CLSD 20.4M
  • FOXX 16.9M
  • IPO Year
  • CLSD 2016
  • FOXX N/A
  • Fundamental
  • Price
  • CLSD $2.75
  • FOXX $3.57
  • Analyst Decision
  • CLSD Hold
  • FOXX
  • Analyst Count
  • CLSD 4
  • FOXX 0
  • Target Price
  • CLSD $75.00
  • FOXX N/A
  • AVG Volume (30 Days)
  • CLSD 42.9K
  • FOXX 2.5M
  • Earning Date
  • CLSD 11-14-2025
  • FOXX 11-18-2025
  • Dividend Yield
  • CLSD N/A
  • FOXX N/A
  • EPS Growth
  • CLSD N/A
  • FOXX N/A
  • EPS
  • CLSD N/A
  • FOXX N/A
  • Revenue
  • CLSD $3,329,000.00
  • FOXX $63,030,415.00
  • Revenue This Year
  • CLSD $98.20
  • FOXX N/A
  • Revenue Next Year
  • CLSD $213.77
  • FOXX N/A
  • P/E Ratio
  • CLSD N/A
  • FOXX N/A
  • Revenue Growth
  • CLSD N/A
  • FOXX 139.29
  • 52 Week Low
  • CLSD $2.54
  • FOXX $1.71
  • 52 Week High
  • CLSD $17.10
  • FOXX $11.00
  • Technical
  • Relative Strength Index (RSI)
  • CLSD 33.87
  • FOXX 52.86
  • Support Level
  • CLSD $2.54
  • FOXX $1.71
  • Resistance Level
  • CLSD $4.00
  • FOXX $3.48
  • Average True Range (ATR)
  • CLSD 0.34
  • FOXX 0.56
  • MACD
  • CLSD -0.16
  • FOXX -0.03
  • Stochastic Oscillator
  • CLSD 10.47
  • FOXX 62.42

About CLSD Clearside Biomedical Inc.

Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.

About FOXX Foxx Development Holdings Inc. Common Stock

Foxx Development Holdings Inc is a consumer electronics and integrated Internet-of-Things (IoT) solution company catering to both retail and institutional clients. With robust research and development capabilities and a strategic commitment to cultivating long-term partnerships with mobile network operators, distributors, and suppliers. Its products include tablets, smartphones, wearables, and other high-quality communication terminals.

Share on Social Networks: